DEERFIELD, Ill. / Oct 23, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the UBS Global Healthcare Conference on Wednesday, November 13, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:15 p.m. Pacific Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday, May 12,... Read More

DEERFIELD, Ill. / Oct 16, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2024 financial results on Friday, November 8, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/attendee/391655054 to pre-register for the call and receive the call information. This call... Read More

Baxter’s North Cove facility affected by flooding and currently closed for production as the company assesses extent of the impact Company is working closely with FDA, ASPR, HHS, FEMA, Department of Homeland Security and local and state officials Baxter and the Baxter International Foundation are committed to supporting recovery efforts in impacted local communities DEERFIELD, Ill. / Sep 29, 2024 / Business Wire / Baxter... Read More

Provides patients with certain chronic lung conditions and retained secretions added comfort, user-friendly touch screen and unique garment design options Developed in consultation with clinicians and patients for an enhanced user experience The Vest uses High Frequency Chest Wall Oscillation therapy, a therapy for which Hillrom, now part of Baxter, has been a pioneer and industry leader BOSTON / Sep 26, 2024 / Business Wire... Read More

Addition of Mr. Craig complements current board expertise with deep financial, broad operational and public company board experience DEERFIELD, Ill. / Sep 09, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Jeffrey (Jay) A. Craig, former executive chair and chief executive officer (CEO) of Meritor Corporation, to its board of directors. Mr. Craig will... Read More

DEERFIELD, Ill. / Aug 28, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 2024 Wells Fargo Healthcare Conference on Thursday, September 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 1:30 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Tuesday,... Read More

Establishes Vantive as a leading standalone kidney care business backed by Carlyle’s global investment team and resources Sale follows robust process focused on maximizing stockholder value Provides increased flexibility to deploy capital toward opportunities to accelerate Baxter’s and Vantive’s respective growth objectives Represents key milestone in Baxter’s ongoing business transformation, enabling heightened strategic... Read More

Second-quarter sales from continuing operations of $3.81 billion increased 3% on a reported basis and 4% on a constant currency basis, exceeding the company’s previously issued guidance and delivering constant currency growth across all segments 1 Second-quarter U.S. GAAP 2 diluted earnings per share (EPS) from continuing operations were ($0.62) and adjusted diluted EPS from continuing operations were $0.68, exceeding the... Read More

DEERFIELD, Ill. / Jul 17, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2024 financial results on Tuesday, August 6, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I898552708 to pre-register for the call and receive the call information. This... Read More

DEERFIELD, Ill. / Jul 16, 2024 / Business Wire / Baxter International Inc . (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on Oct. 1, 2024, to stockholders of record as of Aug. 30, 2024. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every day, millions of... Read More

Provides updates on Baxter’s 2030 Corporate Responsibility Commitment and Goals and reinforces the company’s commitment to transparent reporting DEERFIELD, Ill. / Jul 10, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2023 Corporate Responsibility Report . The annual report showcases Baxter’s dedication to making a meaningful difference in global healthcare and... Read More

DEERFIELD, Ill. / Jun 06, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Goldman Sachs 45 th Annual Global Healthcare Conference on Wednesday, June 12, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay... Read More

Four-year study involved more than 1,000 dialysis patients from a large dialysis provider in Colombia Study compared Baxter’s HDx therapy enabled by Theranova dialyzer with high-flux hemodialysis DEERFIELD, Ill. / May 29, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, today announced new data showing expanded hemodialysis, known as HDx therapy, enabled... Read More

DEERFIELD, Ill. / May 23, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies 2024 Global Healthcare Conference on Wednesday, June 5, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 9:30 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Monday,... Read More

DEERFIELD, Ill. / May 15, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, announced today the mission and logo for its proposed kidney care and acute therapies company, to be named Vantive . The Vantive mission, Extending Lives, Expanding Possibilities , will guide and inspire the proposed company, which will focus on vital organ therapies for acute and chronic kidney diseases and... Read More

Clinolipid provides calories and essential fatty acids for parenteral nutrition Expanded indication demonstrates Baxter’s continued commitment to meeting the diverse nutritional needs of patients, from preterm neonates to adults DEERFIELD, Ill. / May 13, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global leader in nutrition therapy, today announced U.S. FDA approval of an expanded indication for Clinolipid... Read More

DEERFIELD, Ill. / May 07, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Bank of America 2024 Health Care Conference on Wednesday, May 15, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 3:00 p.m. Pacific Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through Wednesday,... Read More

DEERFIELD, Ill. / May 07, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on July 1, 2024, to stockholders of record as of May 31, 2024. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every day, millions of... Read More

First-quarter sales from continuing operations of $3.59 billion increased 2% on a reported basis and 3% on a constant currency basis, exceeding the company’s previously issued guidance 1 First-quarter U.S. GAAP 2 diluted earnings per share (EPS) from continuing operations were $0.07 and adjusted diluted EPS from continuing operations were $0.65, exceeding the company’s previously issued guidance Baxter now expects full-year... Read More

Five new launches reinforce Baxter’s focus on differentiated products and enhance the company’s Pharmaceuticals portfolio in critical therapeutic areas Products feature ready-to-use formulations to help support patient safety and offer added convenience for healthcare professionals DEERFIELD, Ill. / Apr 11, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global leader in injectables, anesthesia and drug... Read More

DEERFIELD, Ill. / Apr 10, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2024 financial results on Thursday, May 2, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://registrations.events/direct/Q4I215737 to pre-register for the call and receive the call information. This call is... Read More

Novum IQ Infusion Platform now offers large volume and syringe infusion smart pumps on an integrated system with shared innovative digital health solutions to help enhance patient safety and efficiency for clinicians Common user interface and connectivity across both pump modalities are designed to help reduce workflow burden and allow more time focused on patient care DEERFIELD, Ill. / Apr 01, 2024 / Business Wire / Baxter... Read More

DEERFIELD, Ill. / Mar 27, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2024 Annual Meeting) in a virtual format on Tuesday, May 7, 2024 at 9 a.m., Central Time, as disclosed in Baxter’s proxy statement for the 2024 Annual Meeting. Online access to the 2024 Annual Meeting will begin at 8:45 a.m., Central Time. Stockholders will not be... Read More

DEERFIELD, Ill. / Feb 29, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 45th Annual Institutional Investors Conference on Monday, March 4, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 4:00 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay... Read More

DEERFIELD, Ill. / Feb 12, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on April 1, 2024, to stockholders of record as of March 1, 2024. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every day, millions of... Read More

Fourth-quarter sales from continuing operations of $3.89 billion increased 4% on a reported basis and 3% on a constant currency basis 1 Fourth-quarter U.S. GAAP diluted earnings per share (EPS) from continuing operations of $0.14 and adjusted diluted EPS from continuing operations of $0.88 Full-year sales from continuing operations of $14.81 billion increased 2% on a reported basis and 3% on a constant currency basis... Read More

DEERFIELD, Ill. / Jan 04, 2024 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2023 financial results on Thursday, February 8, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/etCeELhb to pre-register for the call and receive the call information. This... Read More

Pilot phase successfully demonstrated proof of concept, with more than six tons of plastic IV bag waste diverted from landfill from Northwestern Memorial Hospital Baxter now expanding pilot to support scalability Program demonstrates Baxter’s and Northwestern Medicine’s commitment to corporate responsibility and waste reduction DEERFIELD, Ill. / Dec 14, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), an... Read More

DEERFIELD, Ill. / Dec 13, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 42 nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024. José (Joe) E. Almeida, Baxter’s chairman, president and chief executive officer, is scheduled to present at 10:30 a.m. Pacific Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be... Read More

Builds on Baxter’s more than 30-year history of reporting on environmental and sustainability performance DEERFIELD, Ill. / Dec 11, 2023 / Business Wire / Baxter International Inc . (NYSE:BAX), a global medtech leader, today published its first report aligned with the Task Force on Climate-related Financial Disclosures (TCFD) recommendations, which were recently incorporated into the International Sustainability Standards... Read More

Program is designed to deliver prevention-focused, climate-resilient water, sanitation and hygiene (WASH) services for families and children in Egypt Builds upon existing partnership that is improving water security in Colombia DEERFIELD, Ill. & NEW YORK / Nov 28, 2023 / Business Wire / The Baxter International Foundation, the philanthropic arm of Baxter International Inc. (NYSE:BAX), and UNICEF, today announced a... Read More

DEERFIELD, Ill. / Nov 14, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on January 2, 2024, to shareholders of record as of December 1, 2023. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every day, millions... Read More

Additional key data presented at the congress indicates how HDx therapy enabled by Theranova dialyzer is helping advance “green” nephrology In total, Baxter supported 17 clinical presentations to advance scientific exchange at ASN: Kidney Week 2023 DEERFIELD, Ill. / Nov 06, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global innovator in kidney care and vital organ support, announced today new data... Read More

Third-quarter revenue from continuing operations of $3.71 billion increased 3% on a reported basis and 2% on a constant currency basis, ahead of the company’s previously issued guidance 1 Third-quarter U.S. GAAP earnings per share (EPS) from continuing operations of $0.09; adjusted EPS from continuing operations of $0.68 exceeded guidance Third-quarter U.S. GAAP EPS in the aggregate (including discontinued operations)... Read More

Helps support faster diagnosis, enabling earlier treatment of eye conditions Enables a more digitally connected primary care exam Facilitates collaboration and education among primary care clinicians, specialists, patients and family members DEERFIELD, Ill. / Oct 16, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a leader in patient monitoring, physical assessment and vision screening products, announced the... Read More

DEERFIELD, Ill. / Oct 03, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Joel Grade as executive vice president and chief financial officer (CFO), reporting to Baxter chairman, president and CEO, José (Joe) E. Almeida, effective Oct. 18, 2023. At that time, Brian Stevens, who has served as the company’s interim CFO since May 31, 2023, will transition to... Read More

DEERFIELD, Ill. / Sep 19, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2023 financial results on Thursday, November 2, 2023 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/etCeELhb to pre-register for the call and receive the call information. This... Read More

DEERFIELD, Ill. / Aug 29, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Morgan Stanley 21st Annual Global Healthcare Conference on Wednesday, September 13, 2023. José (Joe) E. Almeida, Baxter’s chairman, president and chief executive officer, is scheduled to present at 9:30 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at... Read More

BOSTON and NEW YORK , Aug. 24, 2023 /PRNewswire/ -- Advent International ("Advent"), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, today announced they have selected Franco Negron to be chief executive officer (CEO) of BioPharma Solutions (BPS) following its proposed divestiture from Baxter International Inc. (NYSE:BAX). The closing of the... Read More

DEERFIELD, Ill. / Aug 22, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the 2023 Wells Fargo Healthcare Conference on Thursday, September 7, 2023. José (Joe) E. Almeida, Baxter’s chairman, president and chief executive officer is scheduled to present at 8:45 a.m. EST. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for... Read More

Addition of Stephen H. Rusckowski complements and expands current board expertise with deep healthcare industry and public company board experience Michael Mahoney to resign after nearly eight years of board service DEERFIELD, Ill. / Aug 21, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed Stephen (Steve) H. Rusckowski, former chairman, president and chief... Read More

Second-quarter revenues increased 3% on a reported basis and 4% on a constant currency basis, ahead of the company’s previously issued guidance 1 Second-quarter U.S. GAAP earnings (loss) per share (EPS) (including discontinued operations) of ($0.28); adjusted EPS (including discontinued operations) of $0.66 Second-quarter U.S. GAAP EPS from continuing operations of ($0.39); adjusted EPS from continuing operations of $0.55... Read More

DEERFIELD, Ill. / Jul 25, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that Vantive will be the name of the company’s proposed spinoff of its Renal Care and Acute Therapies businesses. Vantive is expected to launch as an independent, publicly traded company by July 2024 or earlier, subject to satisfaction of customary conditions. “Announcing the Vantive name is a... Read More

Marks first passive hemostat for Baxter in the U.S. market, broadening portfolio offering to include a full range of active and passive hemostatic products DEERFIELD, Ill. / Jul 24, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced the launch of... Read More

DEERFIELD, Ill. / Jul 18, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on October 2, 2023, to shareholders of record as of September 1, 2023. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every day,... Read More

Addition of Mr. Ampofo complements and expands current board expertise, reflects focus on continued board refreshment efforts DEERFIELD, Ill. / Jun 29, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has appointed William A. Ampofo II, chair, Supply Chain Operations Council and vice president, Parts & Distribution Services and Supply Chain, Boeing Global Services, to... Read More

Developed in collaboration with nurses and therapists to help ease the burden on critical care teams Supports care teams as they address pulmonary, skin and mobility challenges common in the ICU environment Launches in U.S. with global expansion planned to begin later this year DEERFIELD, Ill. / Jun 29, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), an innovator in connected beds for med-surg and the intensive... Read More

Provides updates on 2030 Corporate Responsibility Commitment and Goals Illustrates actions to create a more sustainable and responsible business model Demonstrates continued prioritization of transparent reporting DEERFIELD, Ill. / Jun 26, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today published its 2022 Corporate Responsibility Report . The annual report, which features... Read More

DEERFIELD, Ill. / Jun 13, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2023 financial results on Thursday, July 27, 2023 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/XvgzXupv to pre-register for the call and receive the call information. This... Read More

DEERFIELD, Ill. / May 24, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies Healthcare Conference on Thursday, June 8, 2023. José (Joe) Almeida, Baxter’s chairman, president and chief executive officer, is scheduled to present at 10:00 a.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for... Read More

Jay Saccaro to depart as CFO; Brian Stevens appointed interim CFO DEERFIELD, Ill. / May 09, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the departure of executive vice president and chief financial officer (CFO) Jay Saccaro. Mr. Saccaro will leave Baxter at the end of May after 21 cumulative years with the company, including the past eight as CFO, to join a company in... Read More

DEERFIELD, Ill. / May 05, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced it has selected Chris Toth to be chief executive officer (CEO) of the company’s planned spinoff of its Renal Care and Acute Therapies businesses. Until the spinoff, which remains subject to... Read More

DEERFIELD, Ill. / May 01, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on July 3, 2023, to shareholders of record as of June 2, 2023. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every day, millions of... Read More

First-quarter revenue of $3.65 billion decreased 2% on a reported basis and increased 2% on a constant currency basis 1 First-quarter U.S. GAAP earnings per share (EPS) totaled $0.09; Adjusted EPS totaled $0.59 Baxter expects full-year 2023 sales growth of 1% to 2% on a reported basis and ~1% on a constant currency basis Baxter expects full-year U.S. GAAP EPS of $1.16 to $1.31 and adjusted EPS of $2.85 to $3.00 DEERFIELD,... Read More

DEERFIELD, Ill. / Apr 19, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the BofA Securities 2023 Health Care Conference on Tuesday, May 9, 2023. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:00 p.m. Eastern Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through November 5,... Read More

DEERFIELD, Ill. / Apr 06, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its first-quarter 2023 financial results on Thursday, April 27, 2023 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/WhpPxesO to pre-register for the call and receive the call information. This... Read More

Supports Baxter’s ongoing efforts to expand its anti-infective portfolio to increase access to essential medications and advance patient care Frozen premix formulation helps support patient safety, simplify medication preparation, and improve operational efficiencies DEERFIELD, Ill. / Apr 04, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today... Read More

New conductive Baxter Patient Warming System minimizes risks associated with forced air warming, reduces noise and waste in the operating room and lessens the burden on clinician workflows Helux Pro Connected Surgical Light features 4K camera, deep cavity lighting to help eliminate shadows and allow for consistent illumination during procedures Floseal + Recothrom is the first and only active flowable hemostat with a... Read More

DEERFIELD, Ill. / Mar 29, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, will host its Annual Meeting of Stockholders (the 2023 Annual Meeting) in a virtual format on Tuesday, May 2, 2023 at 9 a.m., Central Time, as disclosed in Baxter’s proxy statement for the meeting. Online access to the meeting will begin at 8:30 a.m., Central Time. Stockholders will not be able to attend the... Read More

DEERFIELD, Ill. / Feb 14, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.29 per share of common stock. The dividend is payable on April 3, 2023, to shareholders of record as of February 24, 2023. The indicated annual dividend rate is $1.16 per share of common stock. About Baxter Every day, millions... Read More

DEERFIELD, Ill. / Feb 09, 2023 / Business Wire / Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2022, and provided its financial guidance for full-year and first-quarter 2023. “Baxter employees worldwide are embracing the power of our lifesaving Mission to navigate a complex healthcare landscape and respond to sustained demand for our... Read More

Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its fourth-quarter 2022 financial results on Thursday, February 9, 2023 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://conferencingportals.com/event/EmxweYhQ to pre-register for the call and receive the call information. This call is also being webcast and can be accessed... Read More

Planning to spin off the Renal Care and Acute Therapies global business units into an independent, publicly traded company in the next 12-18 months Simplifying operating model and manufacturing footprint to drive strategic clarity, improve operational efficiencies and accelerate future growth Exploring strategic alternatives for BioPharma Solutions business to further enhance focus and improve capital structure Hosting... Read More